Fredrik Frejd

Fredrik Frejd

Company: Affibody

Job title: Chief Scientific Officer


Minimized Radioligand ADCs using Affibody Scaffold Technology – ABY-251 as Model 2:45 pm

• Affibody molecules are very small affinity protein scaffolds (7 kDa) that can be manufactured by chemical synthesis • High contrast tumor targeting ability has been demonstrated clinically in patients with metastatic breast cancer • We have engineered the scaffold for reduced kidney uptake to facilitate radioactive payload therapyRead more

day: day 1 track 1 pm

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.